THE INSTITUTE FOR CANCER RESEARCH
Federal contractor profile
Total Awards
4
Total $
$5.3M
Top Agency
Department of Health and Human Services
NAICS Count
1
Total Awards
4
Total Obligated
$5.3M
Agencies Served
1
Expiring Contracts
2
Top Agencies
| Agency | Awards | Total Obligated |
|---|---|---|
| Department of Health and Human Services | 4 | $5.3M |
Top NAICS Codes
| NAICS Code | Description | Awards |
|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 4 |
Expiring Contracts (2)
75N91022F00002132 days remaining
TASK ORDER TITLE: NEXT GENERATION GP130/IL-6/STAT3 INHIBITORS FOR THE PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER
Department of Health and Human Services|Expires Nov 17, 2026
$1.2M
75N91023F00001366 days remaining
COLORECTAL CANCER (CRC) PREVENTION BY UROLITHIN A IN RODENT CRC MODELS
Department of Health and Human Services|Expires Jul 9, 2027
$1.0M
All Awards
FIRM FIXED PRICE
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS TASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIATED COLORECTAL CANCER IMMUNOPREVENTION
Department of Health and Human Services75N91022F00001$2.1M
FIRM FIXED PRICE
TASK ORDER TITLE: NEXT GENERATION GP130/IL-6/STAT3 INHIBITORS FOR THE PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER
Department of Health and Human Services75N91022F00002$1.2M
FIRM FIXED PRICE
COLORECTAL CANCER (CRC) PREVENTION BY UROLITHIN A IN RODENT CRC MODELS
Department of Health and Human Services75N91023F00001$1.0M
FIRM FIXED PRICE
TASK ORDER TITLE: MICROBIAL METABOLITE MIMICRY, A NANO-DRUG FOR COLON CANCER PREVENTION PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS
Department of Health and Human Services75N91022F00003$948,377
Related insights
Spend by Year
Annual obligated spend trend